Alzheimer Disease Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Alzheimer Disease
  • +2 more
  • Risk Assessment Cognitive Screening
  • Austin, Texas
    Comprehensive Memory Center, UT Health Austin
2021-10-05
Oct 5, 2021
W
Not yet recruiting
  • Mild Cognitive Impairment
  • +2 more
  • Insulin (Humulin® R U-100)
  • +4 more
  • (no location specified)
2021-10-04
Oct 4, 2021
U
Enrolling by invitation
  • Alzheimer Disease
  • +8 more
  • Tele-Savvy
  • Caregiving During Crisis (Educational Program)
  • Farmington, Connecticut
  • +1 more
2021-10-13
Oct 13, 2021
I
Recruiting
  • Alzheimer Disease
  • Blood Brain Barrier (BBB) Disruption
  • New York, New York
  • +2 more
2021-10-08
Oct 8, 2021
T
Recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • North Coast Medical Activadose II
  • Albuquerque, New Mexico
    Mind Research Network
2021-10-11
Oct 11, 2021
C
Recruiting
  • Alzheimer Disease
  • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    2021-10-08
    Oct 8, 2021
    C
    Not yet recruiting
    • Periodontitis
    • Alzheimer Disease
    • sampling of dental plaque and blood sample during the treatment
    • Nice, Chu de Nice, France
      CHU de Nice
    2021-10-01
    Oct 1, 2021
    A
    Active, not recruiting
    • Alzheimer Disease
    • Parkinson Disease
    • Stamford, Connecticut
    • +12 more
    2021-10-12
    Oct 12, 2021
    T
    Recruiting
    • Alzheimer Disease
    • F 18 T807 Flortaucipir
    • Saint Louis, Missouri
      Washington University School of Medicine
    2021-10-13
    Oct 13, 2021
    U
    Completed
    • Alzheimer Disease
    • NeuroPsychiatric Inventory Clinician (NPI-C)
    • Toulouse, France
      Toulouse University Hospital (CHU de Toulouse)
    2021-10-06
    Oct 6, 2021
    T
    Recruiting
    • Alzheimer Disease
    • [11C]-Pittsburgh Compound B ([11C]PiB)
    • F 18 AV-1451 (Flortaucipir)
    • Saint Louis, Missouri
      Washington University School of Medicine
    2021-10-13
    Oct 13, 2021
    U
    Enrolling by invitation
    • Alzheimer Disease
    • PI-2620 tracer for Tau PET scan
    • Fort Worth, Texas
      University of North Texas Health Science Center
    2021-10-12
    Oct 12, 2021
    E
    Recruiting
    • Alzheimer Disease
    • Healthy
    • Cypress, California
    • +8 more
    2021-10-05
    Oct 5, 2021
    A
    Recruiting
    • Alzheimer Disease
    • Sydney, New South Wales, Australia
      Atridia Pty Limited
    2021-10-12
    Oct 12, 2021
    U
    Recruiting
    • Alzheimer Disease
    • +2 more
    • Music lessons
    • Training intervention
    • Bergen, Hordaland, Norway
      Bergen Municipality
    2021-10-12
    Oct 12, 2021
    S
    Recruiting
    • Alzheimer Disease
    • NEUROLITH
    • Vienna, Austria
      Medical University of Vienna
    2021-10-12
    Oct 12, 2021
    B
    Not yet recruiting
    • Alzheimer Disease
    • +2 more
    • Care4AD system
    • Houston, Texas
      Baylor College of Medicine
    2021-10-08
    Oct 8, 2021
    U
    Recruiting
    • Alzheimer Disease
    • Omega-3 treatment
    • Placebo
    • Toulouse, France
      University Hospital Toulouse
    2021-10-11
    Oct 11, 2021
    U
    Enrolling by invitation
    • Alzheimer Disease
    • Mild Cognitive Impairment
    • All Subjects
    • Madison, Wisconsin
      University of Wisconsin-Madison
    2021-10-11
    Oct 11, 2021
    H
    Recruiting
    • Alzheimer Disease
    • Tucson, Arizona
    • +247 more
    2021-10-09
    Oct 9, 2021
    I
    Recruiting
    • Alzheimer Disease
    • Blood Brain Barrier (BBB) Disruption
    • Toronto, Ontario, Canada
      Division of Neurosurgery, Sunnybrook Health Sciences Centre
    2021-10-08
    Oct 8, 2021
    A
    Recruiting
    • Alzheimer Disease
    • Subjective Cognitive Impairment
    • Doppler ultrasonography
    • Biospecimen collection
    • Paris, France
      Broca Hospital APHP
    2021-10-11
    Oct 11, 2021
    N
    Recruiting
    • Mild Cognitive Impairment
    • Alzheimer Disease
    • Canakinumab
    • Placebo
    • Fairfax, Virginia
      Novartis Investigative Site
    2021-10-04
    Oct 4, 2021